Why the study?
Does prophylactic lidocaine infusion reduce myocardial injury biomarkers in patients undergoing coronary revascularisation?
Does prophylactic lidocaine infusion reduce myocardial injury biomarkers in patients undergoing coronary revascularisation?
Prophylactic lidocaine infusion does not provide statistically significant cardioprotection during coronary revascularisation and cannot be recommended as routine treatment.
No takes yet. Share an insight, caveat, or question.
Does not support routine prophylactic lidocaine; leaves open possible benefit in randomized trials of coronary revascularisation.
Rinne et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: